Atomera Provides Third Quarter 2026 Results

Atomera Provides Third Quarter 2026 Results LOS GATOS, Calif., Oct. 29, 2026 /PRNewswire/ -- Atomera Incorporated (NASDAQ: ATOM), a semiconductor materials and technology licensing company, today provided a corporate update and announced financial results for the third quarter ended Sept. 30, 2026.

Recent Company Highlights

Management Commentary

"This quarter we expanded our customer engagements in the advanced logic and memory segments, where AI continues to drive the need for higher transistor performance. Our ground-breaking nano-scale diffusion blocking work for gate-all-around transistors has generated interest not only with the GAA foundries, but also with designers of next generation memory solutions" said Scott Bibaud, president and CEO of Atomera. "While work in our traditional business is taking off, we also took an important step toward commercializing our GaN-on-silicon solutions by signing a joint development agreement with IQE, a leading supplier of compound semiconductor wafers."

Financial Results

The Company incurred a net loss of ($6.0) million, or ($0.15) per basic and diluted share in the third quarter of 2026, compared to a net loss of ($5.6) million, or ($0.17) per basic and diluted share, for the third quarter of 2025. Adjusted EBITDA (a non-GAAP financial measure) in the third quarter of 2026 was a loss of ($4.6) million compared to an adjusted EBITDA loss of ($4.4) million in the third quarter of 2025.

The Company had $34.8 million in cash, cash equivalents and short-term investments as of Sept. 30, 2026, compared to $19.2 million as of December 31, 2025.

The total number of shares outstanding was 39.1 million as of September 30, 2026.

Third Quarter 2026 Results Webinar

Atomera will host a live video webinar today to discuss its financial results and recent progress.

Date: Thursday, Oct. 29, 2026

Time: 2:00 p.m. PT (5:00 p.m. ET)

Webcast: Accessible at https://ir.atomera.com

Note about Non-GAAP Financial Measures

In addition to the unaudited results presented in accordance with generally accepted accounting principles, or GAAP, in this press release, Atomera presents adjusted EBITDA, which is a non-GAAP financial measure. Adjusted EBITDA is determined by taking net loss and eliminating the impacts of interest, depreciation, amortization and stock-based compensation. Our definition of adjusted EBITDA may not be comparable to the definitions of similarly-titled measures used by other companies. We believe that this non-GAAP financial measure, viewed in addition to and not in lieu of our reported GAAP results, provides useful information to investors by providing a more focused measure of operating results. This metric is used as part of the Company's internal reporting to evaluate its operations and the performance of senior management. A table reconciling this measure to the comparable GAAP measure is available in the accompanying financial tables below.

About Atomera Incorporated

Atomera Incorporated is a semiconductor materials and technology licensing company focused on deploying its proprietary, silicon-proven technology into the semiconductor industry. Atomera has developed Mears Silicon Technology™ (MST ®), which increases performance and power efficiency in semiconductor transistors. MST can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nano-scaling technologies already in the semiconductor industry roadmap. More information can be found at www.atomera.com.

Safe Harbor

This press release contains forward-looking statements concerning Atomera Incorporated, including statements regarding the prospects for the semiconductor industry generally and the ability of our MST technology to significantly improve semiconductor performance. Those forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially. Among those factors are: (1) the fact that, to date, we have only recognized minimal engineering services and licensing revenues thus subjecting us to all the risks inherent in an early-stage enterprise; (2) the risk that licensees or JDA customers do not advance to royalty-based manufacturing and distribution licenses; (3) our ability to add other licensees and/or JDA customers; (4) risks related to our ability to raise sufficient capital, as and when needed, to pursue the further development, licensing and commercialization of our MST technology; (5) our ability to protect our proprietary technology, trade secrets and know-how and (6) those other risks disclosed in the section "Risk Factors" included in our Annual Report on Form 10-K filed with the SEC on February 24, 2026. We caution readers not to place undue reliance on any forward-looking statements. We do not undertake, and specifically disclaim any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.

-- Financial Tables Follow –

Atomera Incorporated

Condensed Balance Sheets

(in thousands, except per share data)

September 30,

December 31,

2026

2025

(Unaudited)

ASSETS

Current assets:

Cash and cash equivalents

23,268

19,210

Short-term investments

11,560

–

Interest receivable

152

Prepaid expenses and other current assets

456

338

Total current assets

35,436

19,602

Property and equipment, net

Security deposit

Operating lease right-of-use asset

2,731

884

Financing lease right-of-use-asset

196

533

Total assets

38,439

21,093

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:

Accounts payable

868

608

Accrued expenses

522

168

Accrued payroll related expenses

1,326

650

Current operating lease liability

1,908

147

Current financing lease liability

198

420

Deferred Revenue

–

Total current liabilities

4,822

2,000

Long-term operating lease liability

823

712

Total liabilities

5,645

2,712

Commitments and contingencies

–

Stockholders' equity:

–

Preferred stock $0.001 par value, authorized 2,500 shares; none issued and

outstanding as of September 30, 2026 and December 31, 2025

Common stock: $0.001 par value, authorized 95,000 shares; 39,083 shares issued and

outstanding as of September 30, 2026; and 32,354 shares issued and outstanding as

of December 31, 2025

Additional paid in capital

292,874

260,043

Other comprehensive income (loss)

(10)

–

Accumulated deficit

(260,109)

(241,694)

Total stockholders' equity

32,794

18,381

Total liabilities and stockholders' equity

38,439

21,093

Atomera Incorporated

Condensed Statements of Operations

(Unaudited)

(in thousands, except per share data)

Three Months Ended

Nine Months Ended

September 30,

June 30,

September 30,

2026

2025

2026

2025

Revenue

–

158

169

Cost of revenue

–

(26)

(128)

(152)

(190)

Gross margin

–

132

(117)

(175)

Operating expenses

Research and development

3,647

3,287

3,304

10,391

9,563

General and administrative

2,338

3,167

2,165

7,838

6,301

Selling and marketing

343

437

207

1,199

472

Total operating expenses

6,328

6,891

5,676

19,428

16,336

Loss from operations

(6,328)

(6,759)

(5,793)

(19,411)

(16,511)

Other income (expense)

Interest income

254

172

232

623

736

Accretion income

178

–

310

Interest expense

(7)

(1)

(12)

(51)

Other income, net

–

Total other income, net

322

423

220

996

762

Net loss

(6,006)

(6,336)

(5,573)

(18,415)

(15,749)

Net loss per common share, basic and diluted

(0.15)

(0.17)

(0.49)

(0.51)

Weighted average number of common shares

outstanding, basic and diluted

38,899

38,647

31,128

37,614

30,593

Atomera Incorporated

Reconciliation to Non-GAAP EBITDA

(Unaudited)

Three Months Ended

Nine Months Ended

September 30,

June 30,

September 30,

2026

2025

2026

2025

Net loss (GAAP)

(6,006)

(6,336)

(5,573)

(18,415)

(15,749)

Depreciation and amortization

Stock-based compensation

1,746

1,741

1,342

4,893

3,629

Interest income

(254)

(172)

(232)

(623)

(736)

Accretion income

(75)

(178)

–

(310)

(6)

Interest expense

Other income, net

–

(74)

–

(75)

(71)

Net loss non-GAAP EBITDA

(4,572)

(5,012)

(4,440)

(14,493)

(12,847)

SOURCE Atomera Incorporated